Asset
Amlodipine Besylate
Purple Biotech Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (11)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00412113 | phase4 | completed | 2007-01-01 | 2008-04-01 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk |
| NCT00841542 | phase1 | completed | 2003-04-01 | 2003-05-01 | Teva Pharmaceuticals USA | Amlodipine 10 mg Tablets Under Fasting Conditions |
| NCT00841815 | phase1 | completed | 2003-04-01 | 2003-05-01 | Teva Pharmaceuticals USA | Amlodipine 10 mg Tablets Under Fed Conditions |
| NCT02295046 | phase1 | completed | 2011-10-01 | 2011-10-01 | Dr. Reddy's Laboratories Limited | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition |
| NCT02292069 | phase1 | completed | 2011-09-01 | 2011-09-01 | Dr. Reddy's Laboratories Limited | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 210045 | NDA | PURPLE BIOTECH LTD |
Marketed products (3)
- CONSENSI
- CONSENSI
- CONSENSI